HRC president calls on manufacturer to roll back 5,000 percent price hike on HIV drug
WASHINGTON – Human Rights Campaign (HRC) President Chad Griffin today issued an open letter to Turing Pharmaceuticals CEO Martin Shkreli, calling on him to rescind his outrageous 5,000 percent price increase for Daraprim, a drug used to treat people with compromised immune systems, including those living with HIV. The drug, called Daraprim, was acquired in…